1 |
bone mineral density
(24985 times)
|
Orthopedics (6024 times)
|
DXA (3407 times) BMI (1522 times) BMC (1423 times)
|
1982 Differential effects of endocrine dysfunction on the axial and the appendicular skeleton.
|
2 |
Becker muscular dystrophy
(541 times)
|
Neurology (152 times)
|
DMD (337 times) MLPA (32 times) CK (21 times)
|
1980 Serum myoglobin in muscular dystrophy.
|
3 |
benchmark dose
(346 times)
|
Toxicology (177 times)
|
NOAEL (24 times) POD (24 times) BMDL (22 times)
|
1994 Dose-response assessment for developmental toxicity. I. Characterization of database and determination of no observed adverse effect levels.
|
4 |
broth microdilution
(318 times)
|
Microbiology (157 times)
|
CA (42 times) MIC (40 times) CLSI (38 times)
|
1987 Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure.
|
5 |
bone mass density
(193 times)
|
Endocrinology (21 times)
|
BMI (18 times) DXA (12 times) CD (10 times)
|
1992 Effect of growth hormone therapy on IGF-I, bone GLA-protein and bone mineral content in short children with and without chronic renal failure.
|
6 |
bacitracin methylene disalicylate
(50 times)
|
Veterinary Medicine (34 times)
|
FCR (8 times) NE (7 times) FI (5 times)
|
1985 Bacitracin methylene disalicylate in broiler breeder feeds.
|
7 |
broth microdilution method
(30 times)
|
Microbiology (9 times)
|
MIC (6 times) MICs (4 times) MRSA (3 times)
|
2004 Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae.
|
8 |
Best macular dystrophy
(25 times)
|
Ophthalmology (10 times)
|
RPE (4 times) mfERG (3 times) OCT (3 times)
|
1982 Histopathology of Best's macular dystrophy.
|
9 |
bone mineral density measurements
(20 times)
|
Endocrinology (3 times)
|
BMI (3 times) HRT (3 times) DEXA (2 times)
|
1991 [Isolated osteoporosis in a case with Cushing's disease: development after treatment].
|
10 |
bone marrow-derived
(17 times)
|
Neoplasms (3 times)
|
CEC (2 times) GFP (2 times) BMP-2 (1 time)
|
1990 Induction of mixed lymphocyte reaction nonresponsiveness after chimeric thymus transplantation.
|
11 |
brimonidine
(17 times)
|
Ophthalmology (6 times)
|
RGC (5 times) FG (4 times) RGCs (4 times)
|
2001 Brimonidine's neuroprotective effects against transient ischaemia-induced retinal ganglion cell death.
|
12 |
borderline or mild dyskaryosis
(15 times)
|
Neoplasms (12 times)
|
HR-HPV (9 times) CI (4 times) CIN (4 times)
|
2001 High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
|
13 |
bipolar mood disorder
(12 times)
|
Neurology (4 times)
|
ADHD (5 times) EEG (4 times) 1NN (1 time)
|
1995 Is puerperal psychosis bipolar mood disorder?: a phenomenological comparison.
|
14 |
Bernese Mountain Dogs
(11 times)
|
Veterinary Medicine (7 times)
|
ED (2 times) SNP (2 times) Ap (1 time)
|
1995 Inheritance of histiocytosis in Bernese mountain dogs.
|
15 |
bone densitometry
(10 times)
|
Metabolism (3 times)
|
PTH (2 times) ALP (1 time) ApoA1 (1 time)
|
1997 Bone loss and turnover after cardiac transplantation.
|
16 |
Borrelia miyamotoi disease
(9 times)
|
Microbiology (5 times)
|
BmaA (1 time) HBD (1 time) LB (1 time)
|
2015 Borrelia miyamotoi Disease in the Northeastern United States: A Case Series.
|
17 |
Best vitelliform macular dystrophy
(6 times)
|
Ophthalmology (4 times)
|
ADVIRC (1 time) AVMD (1 time) EOG (1 time)
|
1996 Macular flicker electroretinograms in Best vitelliform dystrophy.
|
18 |
brain metabolic DNA
(6 times)
|
Neurology (5 times)
|
BrdU (1 time)
|
2016 Brain metabolic DNA in memory processing and genome turnover.
|
19 |
benchmark dose modeling
(5 times)
|
Toxicology (4 times)
|
POD (2 times) ATSDR (1 time) BMDL (1 time)
|
2000 Reducing uncertainty in the derivation and application of health guidance values in public health practice. Dioxin as a case study.
|
20 |
beta-methyl-digoxin
(5 times)
|
Medicine (2 times)
|
AF (1 time) CI (1 time) HR (1 time)
|
1977 Comparative pharmacodynamics of betamethyl digoxin and digoxin in man.
|
21 |
betamethasone dipropionate
(5 times)
|
Biochemistry (2 times)
|
ANN (1 time) BA (1 time) BHT (1 time)
|
2000 Comparison between micellar electrokinetic chromatography and HPLC for the determination of Betamethasone Dipropionate, Clotrimazole and their related substances.
|
22 |
BMDvol
(5 times)
|
Pediatrics (2 times)
|
IH (2 times) BMC (1 time) BMI (1 time)
|
2001 Regular physical exercise and bone mineral density: a four-year controlled randomized trial in middle-aged men. The DNASCO study.
|
23 |
bone mineral content and density
(5 times)
|
Orthopedics (1 time)
|
LS (2 times) ADT (1 time) BMAD (1 time)
|
1996 Body composition in children with renal disease: use of dual energy X-ray absorptiometry.
|
24 |
brown muscle disease
(5 times)
|
Zoology (2 times)
|
BUR (1 time) CI (1 time) SURF (1 time)
|
2008 Brown muscle disease (BMD), an emergent pathology affecting Manila clam Ruditapes philippinarum in Arcachon Bay (SW France).
|
25 |
Burning mouth disorder
(5 times)
|
Dentistry (3 times)
|
fMRI (1 time)
|
2003 Burning mouth (syndrome) disorder.
|
26 |
Beckers MD
(4 times)
|
Physiology (1 time)
|
DMD (4 times) MD (4 times) LGMD (2 times)
|
1993 Dystrophin analysis in the diagnosis of childhood muscular dystrophy: an immunohistochemical study of 75 cases.
|
27 |
bilateral Meniere's disease
(4 times)
|
Otolaryngology (4 times)
|
CA (1 time) PARP-1 (1 time) PTPN22 (1 time)
|
1991 Bilateral Meniere's disease in surgical versus nonsurgical patients.
|
28 |
bone mass densitometry
(4 times)
|
Allergy and Immunology (1 time)
|
CME (1 time) COPD (1 time) DEXA (1 time)
|
2002 Does patient partnership in continuing medical education (CME) improve the outcome in osteoporosis management?
|
29 |
bone mineral disease
(4 times)
|
Medicine (2 times)
|
BALP (1 time) CAC (1 time) CD (1 time)
|
2003 Correlations of new markers of bone formation and resorption in kidney transplant recipients.
|
30 |
B. miyamotoi disease
(3 times)
|
Natural Science Disciplines (1 time)
|
uPA (2 times) EIA (1 time) Vlps (1 time)
|
2018 The Complement Binding and Inhibitory Protein CbiA of Borrelia miyamotoi Degrades Extracellular Matrix Components by Interacting with Plasmin(ogen).
|
31 |
Bangladesh Meteorological Department
(3 times)
|
Environmental Health (2 times)
|
AH (1 time) ARIMA (1 time) COVID-19 (1 time)
|
2017 Exploring standardized precipitation evapotranspiration index for drought assessment in Bangladesh.
|
32 |
Behavioural and Mood Disturbance scale
(3 times)
|
Medicine (2 times)
|
CAPE (1 time) CI (1 time) HD (1 time)
|
1991 Caring for dementia sufferers in the community: the caregivers problems.
|
33 |
BMDLs
(3 times)
|
Environmental Health (1 time)
|
BMR (1 time) Cr (1 time) FCd (1 time)
|
2011 A signal-to-noise crossover dose as the point of departure for health risk assessment.
|
34 |
Boehringer Mannheim Diagnostics
(3 times)
|
Chemistry, Clinical (2 times)
|
EK (1 time) LD (1 time) REP (1 time)
|
1986 Assays of serum lipase: analytical and clinical considerations.
|
35 |
Bone mineral density of the lumbar spine
(3 times)
|
Emergency Medicine (1 time)
|
B-AIP (1 time) BGP (1 time) DEXA (1 time)
|
1994 [Bone mineral density of lumbar spine and its relations to biological and lifestyle factors in middle-aged and aged Japanese women (Part 2). Effects of age and menopause on bone mineral density evaluated by biochemical markers of bone metabolism].
|
36 |
borderline mental disorders
(3 times)
|
Neurology (2 times)
|
---
|
1997 [The prevalence of borderline mental disorders in persons of either sex].
|
37 |
brain metastatic disease
(3 times)
|
Neoplasms (3 times)
|
EOC (2 times) CC (1 time) cSRE (1 time)
|
2009 Brain metastases in epithelial ovarian and primary peritoneal carcinoma.
|
38 |
(E)-bromomethoxydiene
(2 times)
|
Chemistry (1 time)
|
---
|
2016 Synthesis of (E)-4-Bromo-3-methoxybut-3-en-2-one, the Key Fragment in the Polyhydroxylated Chain Common to Oscillariolide and Phormidolides A-C.
|
39 |
basement membrane degeneration
(2 times)
|
Neoplasms (2 times)
|
BLI (1 time) BM (1 time) CB (1 time)
|
1997 Proteinase inhibitors reduce basement membrane degradation by human breast cancer cell lines.
|
40 |
beached marine debris
(2 times)
|
Environmental Health (2 times)
|
SMD (2 times) FMD (1 time) SMSFMD (1 time)
|
2011 The abundance, composition and sources of marine debris in coastal seawaters or beaches around the northern South China Sea (China).
|
41 |
beclomethasone dipropionate
(2 times)
|
Medicine (1 time)
|
BMV (1 time) CP (1 time) DEX (1 time)
|
1982 [Comparative toxicity test of dexamethasone valerate (DV-17) and other steroid ointments in rats].
|
42 |
benchmark dose approach
(2 times)
|
Environmental Health (2 times)
|
BLV (1 time) BMD-CI (1 time) BMDL (1 time)
|
2020 Mixture effects of chemicals: The difficulty to choose appropriate mathematical models for appropriate conclusions.
|
43 |
bimodal dialysis
(2 times)
|
Nephrology (1 time)
|
HD (2 times) PD (2 times) ESRD (1 time)
|
2004 Bimodal dialysis: an integrated approach to renal replacement therapy.
|
44 |
Biomedical Diagnostics
(2 times)
|
Pharmacology (1 time)
|
ANA (1 time) ATI (1 time) RA (1 time)
|
2007 Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera.
|
45 |
bioprocess-centered molecular design
(2 times)
|
Biomedical Engineering (1 time)
|
KSI (1 time)
|
2004 Bioprocess-centered molecular design (BMD) for the efficient production of an interfacially active peptide.
|
46 |
bis(4-methylbenzoyl) diselenide
(2 times)
|
Pharmacy (1 time)
|
AST (1 time) BK (1 time) CFA (1 time)
|
2012 Hepatoprotective effect of bis(4-methylbenzoyl) diselenide against CCl(4)-induced oxidative damage in mice.
|
47 |
blueberry mosaic disease
(2 times)
|
Virology (1 time)
|
BlMaV (1 time) RT-PCR (1 time)
|
2014 A new ophiovirus is associated with blueberry mosaic disease.
|
48 |
BM density
(2 times)
|
Medicine (1 time)
|
BM (2 times) DAS28 (1 time) GD (1 time)
|
2015 Occurrence of osteoporosis & factors determining bone mineral loss in young adults with Graves' disease.
|
49 |
BM donors
(2 times)
|
Virology (1 time)
|
BM (2 times) BMT (1 time) HBsAg (1 time)
|
1995 Immunization against hepatitis B through adoptive transfer of immunity.
|
50 |
BMD z-score
(2 times)
|
Hematology (1 time)
|
BMI (1 time) DEXA (1 time) DXA (1 time)
|
2007 Evaluation of bone mineral density in children with hemophilia: Mansoura University children hospital (MUCH) experience, Mansoura, Egypt.
|
51 |
BMDcort
(2 times)
|
Metabolism (1 time)
|
PBM (1 time) SCI (1 time)
|
2004 Assessment of anthropometric, systemic, and lifestyle factors influencing bone status in the legs of spinal cord injured individuals.
|
52 |
bone marrow depression
(2 times)
|
Psychiatry (1 time)
|
AML (1 time) CR (1 time) OR (1 time)
|
1975 Outpatient phenothiazine use and bone marrow depression. A report from the drug epidemiology unit and the Boston collaborative drug surveillance program.
|
53 |
bone marrow disease
(2 times)
|
Nuclear Medicine (2 times)
|
BMB (2 times) NHL (2 times) CT (1 time)
|
2008 FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
|
54 |
bone morphogenic density
(2 times)
|
Orthopedics (1 time)
|
LOS Questionnaire (1 time)
|
2011 Anamnestic risk factor questionnaire as reliable diagnostic instrument for osteoporosis (reduced bone morphogenic density).
|
55 |
bone morphology and mineral density
(2 times)
|
Environmental Health (1 time)
|
Cd-U (1 time) muCT (1 time)
|
2010 The effects of low environmental cadmium exposure on bone density.
|
56 |
bone turnover, mineral density
(2 times)
|
Endocrinology (1 time)
|
ACS (1 time) BFR (1 time) DXA (1 time)
|
2009 BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism.
|
57 |
markers--bone mineral density
(2 times)
|
Metabolism (1 time)
|
ALP (1 time) BTM (1 time) CTX (1 time)
|
2007 Fracture risk remains reduced one year after discontinuation of risedronate.
|
58 |
milder Becker
(2 times)
|
Neurology (1 time)
|
DMD (2 times) IHC (1 time) MD STARnet (1 time)
|
2013 Clinical, immunohistochemical, Western blot, and genetic analysis in dystrophinopathy.
|
59 |
N1-benzyl-4-methylbenzene-1,2-diamine
(2 times)
|
Pharmacology (2 times)
|
iNOS (2 times) LPS (2 times) NF (2 times)
|
2005 Anti-inflammatory benzene diamine compound inhibited toll-like receptor 4-mediated inducible nitric oxide synthase expression and nuclear factor-kappa B activation.
|
60 |
4-hydroxybenzhydrazide-modified doxorubicin
(1 time)
|
Biocompatible Materials (1 time)
|
HCCP (1 time)
|
2020 One-pot synthesis of acid-degradable polyphosphazene prodrugs for efficient tumor chemotherapy.
|
61 |
4-tert-butyl-4'-methoxydibenzoylmethane
(1 time)
|
Pharmacology (1 time)
|
UV (1 time)
|
1991 [High performance liquid chromatographic analysis of typical ultraviolet absorbers in cosmetic products].
|
62 |
bacitracin dimethyl salicyclate
(1 time)
|
Medicine (1 time)
|
AGP (1 time)
|
2018 Effect of antibiotic withdrawal in feed on chicken gut microbial dynamics, immunity, growth performance and prevalence of foodborne pathogens.
|
63 |
BACKGROUND: In Mexico, calcaneal ultrasound measurements -bone mineral density
(1 time)
|
Medicine (1 time)
|
BUA (1 time) DIF (1 time) QUI (1 time)
|
2014 [Menopause and ultrasonographic measurements of calcaneus].
|
64 |
Baimudan
(1 time)
|
Chemistry (1 time)
|
BHYZ (1 time) EPSFs (1 time)
|
2018 Metabolomics Investigation Reveals That 8-C N-Ethyl-2-pyrrolidinone-Substituted Flavan-3-ols Are Potential Marker Compounds of Stored White Teas.
|
65 |
balanced mix design
(1 time)
|
|
APA (1 time) RAP (1 time)
|
2020 Application of Balanced Mix Design Methodology to Optimize Surface Mixes with High-RAP Content.
|
66 |
based on pair-wise agreements with the reference method
(1 time)
|
Microbiology (1 time)
|
AD (1 time) EA (1 time) MTS (1 time)
|
2021 Performance of different methods for testing polymyxin B: comparison of broth microdilution, agar dilution and MIC test strip in mcr-1 positive and negative Escherichia coli.
|
67 |
baseline MD
(1 time)
|
Breast Neoplasms (1 time)
|
BC (1 time) CBC (1 time) MD (1 time)
|
2019 Are mammographic density phenotypes associated with breast cancer treatment response and clinical outcomes? A systematic review and meta-analysis.
|
68 |
basic manual dexterity
(1 time)
|
Dentistry (1 time)
|
BMDS (1 time)
|
2007 Is manual dexterity essential in the selection of dental students?
|
69 |
basis material decomposition
(1 time)
|
|
BMT (1 time) DXCT (1 time) SPECT (1 time)
|
2021 Dual-energy x-ray approach for object/energy-specific attenuation coefficient correction in single-photon emission computed tomography: effects of contrast agent.
|
70 |
basis of the results of densitometric analysis
(1 time)
|
Medicine (1 time)
|
---
|
2007 The relationship between mineral status of the organism and the number of teeth present and periodontal condition in postmenopausal patients.
|
71 |
Bayesian microsaccade detection
(1 time)
|
Ophthalmology (1 time)
|
---
|
2017 Bayesian microsaccade detection.
|
72 |
Becker muscular dystrophy patients
(1 time)
|
Medicine (1 time)
|
DMD (1 time)
|
2015 DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations.
|
73 |
bedside medication delivery
(1 time)
|
Health Services (1 time)
|
---
|
2019 Bedside medication delivery programs: suggestions for systematic evaluation and reporting.
|
74 |
been associated with mild
(1 time)
|
Medicine (1 time)
|
---
|
2003 Large in-frame deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype.
|
75 |
Behaviors and Mental Disorders
(1 time)
|
Biotechnology (1 time)
|
NSD (1 time)
|
2010 Dynamic, multi-level network models of clinical trials.
|
76 |
Bekker's myodystrophy
(1 time)
|
Therapeutics (1 time)
|
CPK (1 time) DMD (1 time) LV (1 time)
|
2007 [Characteristics of cardiomyopathy in recessive X-linked myodystrophy with a rapid and slow course].
|
77 |
Bembezar Margen Derecha
(1 time)
|
Environmental Health (1 time)
|
GHG (1 time) NSGAII (1 time)
|
2013 New model for sustainable management of pressurized irrigation networks. Application to Bembezar MD irrigation district (Spain).
|
78 |
Benchmark dose analyses
(1 time)
|
Environmental Health (1 time)
|
POD (1 time) TBT (1 time)
|
2020 Transcriptomic effects of tributyltin (TBT) in zebrafish eleutheroembryos. A functional benchmark dose analysis.
|
79 |
benchmark dose analyzing
(1 time)
|
Genetics (1 time)
|
DSP (1 time) DTX-1 and -2 (1 time) EFSA (1 time)
|
2020 Benchmark dose analyses of gammaH2AX and pH3 endpoints for quantitative comparison of in vitro genotoxicity potential of lipophilic phycotoxins.
|
80 |
benchmark dose methods
(1 time)
|
Medicine (1 time)
|
---
|
1999 [Application of BMD models in quantitative evaluation of carcinogenic risk].
|
81 |
benchmark dose value
(1 time)
|
Pharmacology (1 time)
|
ABC (1 time) EGME (1 time) GSA (1 time)
|
2018 A Computational Workflow for Probabilistic Quantitative in Vitro to in Vivo Extrapolation.
|
82 |
benchmark dose-response modelling
(1 time)
|
Environmental Health (1 time)
|
BMDLs (1 time) OEL (1 time) sd (1 time)
|
2021 A health-based recommended occupational exposure limit for nitrous oxide using experimental animal data based on a systematic review and dose-response analysis.
|
83 |
benign mammary dysplasia
(1 time)
|
Neoplasms (1 time)
|
---
|
1982 The comparative epidemiology of benign breast lumps and breast cancer in Western Australia.
|
84 |
benzamidine
(1 time)
|
Biochemistry (1 time)
|
PMSF (1 time) SVTLEs (1 time)
|
2010 Molecular mechanism analysis of Gloydius shedaoensis venom gloshedobin interaction with inhibitors by homology modeling.
|
85 |
bermudagrass silage
(1 time)
|
Veterinary Medicine (1 time)
|
DM (1 time) TMR (1 time) XYL (1 time)
|
2021 Effects of a xylanase-rich enzyme on intake, milk production, and digestibility of dairy cows fed a diet containing a high proportion of bermudagrass silage.
|
86 |
best monosyllabic discrimination
(1 time)
|
Audiology (1 time)
|
CI (1 time) FMD (1 time)
|
2017 Effects of Cerebral Blood Flow and Vessel Conditions on Speech Recognition in Patients With Postlingual Adult Cochlear Implant: Predictable Factors for the Efficacy of Cochlear Implant.
|
87 |
between genotypes for this gene and proximal femur mineral density
(1 time)
|
Molecular Biology (1 time)
|
GI (1 time) SGC (1 time)
|
2012 [Polymorphisms in xenobiotic-metabolizing genes in the pathogenesis of glucocorticoid-induced osteoporosis in patients with bronchial asthma].
|
88 |
between-module degree
(1 time)
|
Brain (1 time)
|
PFC (1 time) rTMS (1 time)
|
2017 Frequency-specific neuromodulation of local and distant connectivity in aging and episodic memory function.
|
89 |
bilateral macular dystrophy
(1 time)
|
Ophthalmology (1 time)
|
CTRL (1 time) FAZ (1 time) OCT (1 time)
|
2012 Detailed functional and structural characterization of a macular lesion in a rhesus macaque.
|
90 |
bilateral Madelung deformity
(1 time)
|
Endocrinology (1 time)
|
LWS (1 time) rhGH (1 time) SDS (1 time)
|
2003 Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency.
|
91 |
bilateral MD cases
(1 time)
|
Otolaryngology (1 time)
|
MD (1 time) UPDV (1 time) UPHL (1 time)
|
1995 Epidemiological study of severe cases of Meniere's disease in Japan.
|
92 |
bilateral mediastinal node dissection
(1 time)
|
Cardiology (1 time)
|
NSCLC (1 time) UMD (1 time)
|
2012 Contralateral mediastinal lymph node micrometastases assessed by video-assisted thoracoscopic surgery in stage I non-small cell left lung cancer.
|
93 |
bimin decoction
(1 time)
|
Medicine (1 time)
|
AR (1 time) LQDCS (1 time) RQLQ (1 time)
|
2020 Efficacy of Bimin decoction for patients with perennial allergic rhinitis: an open-label non-inferiority randomized controlled trial.
|
94 |
biofilm monitoring device
(1 time)
|
Microbiological Phenomena (1 time)
|
DWDS (1 time)
|
2021 Non-invasive Biofouling Monitoring to Assess Drinking Water Distribution System Performance.
|
95 |
biological Maxwell's demons
(1 time)
|
Biology (1 time)
|
---
|
2021 The biological Maxwell's demons: exploring ideas about the information processing in biological systems.
|
96 |
Biomass Distribution
(1 time)
|
Communicable Diseases (1 time)
|
ED (1 time) LSE (1 time)
|
2017 Approaches for quantifying antimicrobial consumption per animal species based on national sales data: a Swiss example, 2006 to 2013.
|
97 |
biomedical
(1 time)
|
Health Services (1 time)
|
BPS (1 time)
|
2016 Physician Assimilation in Medical Schools: Dualisms of Biomedical and Biopsychosocial Ideologies in the Discourse of Physician Educators.
|
98 |
biomedical doctors
(1 time)
|
Complementary Therapies (1 time)
|
MERSQI (1 time) TCAM (1 time)
|
2012 Complementary and alternative medicine education for medical profession: systematic review.
|
99 |
Biomedical Sciences
(1 time)
|
Education (1 time)
|
HCM (1 time) SHP (1 time)
|
2020 Crafting a Team-Based, Interprofessional Undergraduate Research Honors Curriculum in the Health Professions.
|
100 |
biomedically trained doctors
(1 time)
|
Medicine (1 time)
|
IHC (1 time) IPC (1 time) TCAMP (1 time)
|
2012 Organizational determinants of interprofessional collaboration in integrative health care: systematic review of qualitative studies.
|